InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
27%
T+90 mean return
-4.6%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Beraud Jill, Director. Insider active across 2 companies, notably Revance Therapeutics, Inc.. Cumulatively, 33 reports have been published. History available since 5 May 2021. The latest transaction was disclosed on 9 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations33 total
88 shares0Class A Common StockSEC:0001999371-25-005903:0
108,679 shares0Class A Common StockSEC:0001999371-25-004779:0
56 shares0Class A Common StockSEC:0001839882-25-013573:0
28,606 shares@ US$3.65100.0% of flowCommon StockSEC:0000950170-25-015341:0
60 shares0Class A Common StockSEC:0001839882-24-039788:0
52 shares0Class A Common StockSEC:0001999371-24-010538:0
42 shares0Class A Common StockSEC:0001999371-24-006713:0
15,000 shares0Common StockSEC:0001479290-24-000084:0
7,642 shares0Class A Common StockSEC:0001999371-24-005255:0
69 shares0Class A Common StockSEC:0001999371-24-002763:0
87 shares0Class A Common StockSEC:0001999371-23-000150:0
88 shares0Class A Common StockSEC:0001209191-23-046788:0
129 shares0Class A Common StockSEC:0001209191-23-031617:0
3,534 shares0Common StockSEC:0001479290-23-000058:0
10,251 shares0Class A Common StockSEC:0001209191-23-025261:0
77,410 shares0Common StockSEC:0001209191-23-025241:0
87 shares0Class A Common StockSEC:0001209191-23-013528:0
190 shares0Class A Common StockSEC:0001209191-22-058617:0
152 shares0Class A Common StockSEC:0001209191-22-046620:0
222 shares0Class A Common StockSEC:0001209191-22-031970:0
6,059 shares0Common StockSEC:0001479290-22-000060:0
7,812 shares0Class A Common StockSEC:0001209191-22-025345:0
129 shares0Class A Common StockSEC:0001209191-22-013591:0
81 shares0Class A Common StockSEC:0001209191-21-065524
81 shares0Class A Common StockSEC:0001209191-21-065524:0
25 of 33 declarations
About Beraud Jill
Jill Beraud is a Board Member at Revance Therapeutics, Inc. and Levi Strauss & Co. In this role, she contributes to the governance and strategy of the companies. Jill is recognized for her expertise in management and business development, enabling her to provide strategic advice to discussions within the boards. Her varied experience in the industry allows her to provide valuable perspectives to support innovation.
